Results 171 to 180 of about 11,095,042 (285)
Anti-vascular endothelial growth factor therapy for posterior segment diseases: Progress, challenges, and the road ahead. [PDF]
Mishra C +4 more
europepmc +1 more source
Umbilical cord stem cell‐derived exosomes encapsulated in an immunomodulatory bioadhesive hydrogel spray enable localized therapy, sustained vesicle delivery, macrophage polarization, suppress systemic inflammation, and mitigate glucose and insulin homeostasis impairments in MAFLD.
Triya Saha +4 more
wiley +1 more source
Anti-vascular endothelial growth factor drugs in polypoidal choroidal vasculopathy
Jay Kumar Chhablani
doaj +1 more source
Anti-vascular endothelial growth factor therapy in clinical practice: Real-world scenarios, limitations, and outcomes. [PDF]
Sharma D, Gupta T.
europepmc +1 more source
In sepsis‐induced liver injury, marked neutrophil infiltration correlates with disease severity. Neutrophil SLC11A1 drives intracellular Fe2+ and ROS via the Fenton reaction, promoting NETs formation. Hepatocyte‐derived CXCL10 recruits neutrophils and activates the JAK/STAT1/SLC11A1 axis, enhancing NETs‐mediated inflammation.
Haiping Lin +8 more
wiley +1 more source
Electric field‑driven continuous gradient hydrogel GHZF4 achieves spatiotemporal growth factor release, modulates immune microenvironment, angiogenesis and osteochondral differentiation. It realizes cell‑free functional osteochondral repair in rat/rabbit models, offering a promising biomimetic strategy for gradient tissue regeneration.
Xiaolian Niu +7 more
wiley +1 more source
Patient Experiences of Intravitreal Anti-Vascular Endothelial Growth Factor Injections for Age-Related Macular Degeneration: A Meta-Synthesis of Qualitative Studies. [PDF]
Liu D, Bi H, Sun Y, Gao Z, Lu P.
europepmc +1 more source
A double‐layered shell‐core microneedle patch is developed to co‐deliver FOLFIRINOX, surufatinib, and anti‐PD‐1 for localized chemo‐immunotherapy of PDAC. This strategy achieves sustained tumor suppression, reduces metastasis, and reprograms the TME by enhancing CD8+ T‐cell infiltration and inhibiting Tregs and M2 macrophages infiltration, while ...
Tingting Kong +13 more
wiley +1 more source
Low-fluence PDT better than anti-vascular endothelial growth factor
K S Santhan Gopal
doaj +1 more source
Non-intravitreal anti-vascular endothelial growth factor delivery for ocular neovascular diseases: Current status and future directions. [PDF]
Joshi SM +4 more
europepmc +1 more source

